Cerebrovascular Diseases

Stroke Note

Free Access

COL4A1 Mutation Revealed by an Isolated Brain Hemorrhage

Corlobe A.a · Tournier-Lasserve E.c · Mine M.c · Menjot de Champfleur N.b · Carra Dalliere C.a · Ayrignac X.a · Labauge P.a · Arquizan C.a

Author affiliations

Services deaNeurologie and bNeuroradiologie, Hôpital Gui de Chauliac, Montpellier, and cLaboratoire de Génétique, Groupe Hospitalier Lariboisière-Fernand Widal, INSERM UMR-S740, Paris, France

Corresponding Author

Astrid Corlobe, MD

Service de Neurologie, Hôpital Gui de Chauliac

80 avenue Augustin Fliche

FR-34000 Montpellier (France)

E-Mail astrid.corlobe@gmail.com

Related Articles for ""

Cerebrovasc Dis 2013;35:593-594

Introduction

Ten to fifteen percent of strokes are related to an intracerebral hemorrhage (ICH). Etiologies are mainly arterial hypertension, amyloid deposition, and vascular malformations. In cases of a young age without vascular risk factors and vascular malformations, a genetic cause has to be suspected, especially a mutation in the gene coding for type IV collagen alpha 1 (COL4A1)[1].

We report a COL4A1 gene mutation in a 45-year-old woman with an isolated ICH in the absence of any other MRI abnormality, which further extends the clinical spectrum of COL4A1 mutations.

Case Report

A 45-year-old woman, without vascular risk factors, especially hypertension, or any medical history presented a coital thunderclap headache, followed by a right hemiparesis, hemihypoesthesia, and dysarthria. Usual biological analyses, including renal function, were normal. Brain MRI revealed an isolated ICH of the left putamen and internal capsule without any other abnormalities (fig. 1a, b). Microbleeds and leukoencephalopathy were absent. Brain CT scan did not find any calcification. Cerebral angiography was normal. Blood pressure monitoring, electrocardiography, transthoracic echocardiography, Holter monitoring, and a stress test were normal. The ophthalmological examination showed no retinal arteriolar tortuosity or cataracts. Renal ultrasound was normal. A second brain MRI performed 3 months later only showed the sequelae of ICH (fig. 1c, d). Inquiries among relatives were strictly negative. However, because of this unexplained and isolated ICH in a young adult, a genetic cause was strongly suspected.

Fig. 1

Brain MRI. Flair sequence (a) and gradient echo sequence(b). Initial MRI showing an ICH of the left putamen and internal capsule without any other abnormalities. Flair sequence(c) and gradient echo sequence(d). Sequelae of ICH on a further MRI 3 months later.

http://www.karger.com/WebMaterial/ShowPic/187185

The entire COL4A1 gene was sequenced and a heterozygous G-to-A transition (c.2063G>A) was identified in exon 28, leading to the replacement of a highly conserved glycine residue by aspartic acid at position 688 (p.G688D) within the triple-helix domain. This mutation, never described to date, was not found in a panel of 288 control chromosomes of ethnically matched controls, and it is not present in the Exome Variant database or dbSNP137. It was predicted to be deleterious by SIFT, Polyphen, and alignGVD software.

Discussion

The spectrum of COL4A1-related disorders includes perinatal cerebral hemorrhage and porencephaly [2], cerebral small vessel disease with retinal arteriolar tortuosity and leukoencephalopathy [3], HANAC syndrome (Hereditary Angiopathy, Nephropathy, Aneurysms, and Muscle Cramps) and other eye abnormalities, including the Axenfeld-Rieger anomaly and cataract. A frequent white matter involvement is reported [3,4]. Interestingly, some HANAC patients may have a normal brain MRI. However, except for one patient who suffered from migraine, these patients were free from neurologic symptoms [5,6].

Recently, Weng et al. [7] reported COL4A1 variants in 2/96 patients with sporadic ICH. Their phenotype was not described in detail, but they did not seem to present an isolated deep ICH, as did our patient. Indeed, one 73-year-old patient had lobar ICH and microbleeds on his cerebral MRI, and the other patient with deep ICH suffered from hypertension.

Our report extends the clinical and MRI phenotypes of patients with pathogenic COL4A1 mutation. These data strongly suggest that COL4A1 genetic screening should be proposed in young patients with an isolated ICH of undetermined etiology, even without any other MRI abnormalities (microbleeds, leukoencephalopathy), or any family history of neurological manifestations.

Disclosure Statement

No financial disclosure.



Related Articles:


References

  1. Lanfranconi S, Markus HS: COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review. Stroke 2010;41:e513-e518.
  2. Gould DB, Phalan FC, Van Mil SE, et al: Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 2006;354:1489-1496.
  3. Plaisier E, Gribouval O, Alamowitch S, et al: COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Engl J Med 2007;357:2687-2695.
  4. Sibon I, Coupry I, Menegon P, et al: COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke. Ann Neurol 2007;62:177-184.
  5. Alamowitch S, Plaisier E, Favrole P, et al: Cerebrovascular disease related to COL4A1 mutations in HANAC syndrome. Neurology 2009;73:1873-1882.
  6. Plaisier E, Chen Z, Gekeler F, et al: Novel COL4A1 mutations associated with HANAC syndrome: a role for the triple helical CB3[IV] domain. Am J Med Genet A 2010;152A:2550-2555.
  7. Weng YC, Sonni A, Labelle-Dumais C, et al: COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage. Ann Neurol 2012;71:470-477.

Author Contacts

Astrid Corlobe, MD

Service de Neurologie, Hôpital Gui de Chauliac

80 avenue Augustin Fliche

FR-34000 Montpellier (France)

E-Mail astrid.corlobe@gmail.com


Article / Publication Details

Published online: July 10, 2013
Issue release date: July 2013

Number of Print Pages: 2
Number of Figures: 1
Number of Tables: 0

ISSN: 1015-9770 (Print)
eISSN: 1421-9786 (Online)

For additional information: https://www.karger.com/CED


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Lanfranconi S, Markus HS: COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review. Stroke 2010;41:e513-e518.
  2. Gould DB, Phalan FC, Van Mil SE, et al: Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 2006;354:1489-1496.
  3. Plaisier E, Gribouval O, Alamowitch S, et al: COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Engl J Med 2007;357:2687-2695.
  4. Sibon I, Coupry I, Menegon P, et al: COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke. Ann Neurol 2007;62:177-184.
  5. Alamowitch S, Plaisier E, Favrole P, et al: Cerebrovascular disease related to COL4A1 mutations in HANAC syndrome. Neurology 2009;73:1873-1882.
  6. Plaisier E, Chen Z, Gekeler F, et al: Novel COL4A1 mutations associated with HANAC syndrome: a role for the triple helical CB3[IV] domain. Am J Med Genet A 2010;152A:2550-2555.
  7. Weng YC, Sonni A, Labelle-Dumais C, et al: COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage. Ann Neurol 2012;71:470-477.
TOP